CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MOODY ALDRICH PARTNERS LLC | 325,977 | $4,860,317 | 0.92% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $2,982,000 | 0.90% |
EMERALD MUTUAL FUND ADVISERS TRUST | 809,738 | $12,073,194 | 0.73% |
EMERALD ADVISERS, LLC | 983,775 | $14,668,078 | 0.71% |
Lion Point Capital, LP | 82,425 | $1,228,957 | 0.55% |
Monashee Investment Management LLC | 75,000 | $1,118,250 | 0.47% |
TANG CAPITAL MANAGEMENT LLC | 200,000 | $2,982,000 | 0.42% |
Ikarian Capital, LLC | 2,230 | $3,324,930 | 0.40% |
Artia Global Partners LP | 41,261 | $615,202 | 0.26% |
Hood River Capital Management LLC | 512,411 | $7,640,048 | 0.24% |
Atika Capital Management LLC | 116,000 | $1,729,560 | 0.23% |
ADVISORY RESEARCH INC | 104,540 | $1,558,692 | 0.22% |
Golden State Equity Partners | 50,000 | $745,500 | 0.21% |
Holocene Advisors, LP | 3,117,685 | $46,484,683 | 0.20% |
Ikarian Capital, LLC | 104,300 | $1,555,112 | 0.19% |
FRED ALGER MANAGEMENT, LLC | 2,172,309 | $32,389,127 | 0.19% |
Ikarian Capital, LLC | 816 | $1,216,656 | 0.15% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,125,000 | $61,503,750 | 0.14% |
Octagon Capital Advisors LP | 60,000 | $894,600 | 0.14% |
AlphaCentric Advisors LLC | 15,000 | $223,650 | 0.13% |
External links
This page lists CYMABAY THERAPEUTICS INC's shareholders in Q3 2023. To view CYMABAY THERAPEUTICS INC's shareholder history, click here.